Class II
Ongoing
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.
This recall is currently active, issued March 26, 2025. It was issued by Mylan Institutional Inc.
- Company
- Mylan Institutional Inc
- Recall Initiated
- March 7, 2025
- Posted
- March 26, 2025
- Recall Number
- D-0291-2025
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 1,068 cartons
- Firm Location
- Rockford, IL, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Super-Potent Drug: Out of specification potency results were obtained.
Distribution
Nationwide in the USA
Lot / Code Info
Lot 3115773, Exp. 03/31/2025
More recalls by Mylan Institutional Inc
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026